Catalog: | C0061T |
Product Type: | Test kit |
Unit: | 25 tests |
Tested parameter: | 18 high-risk HPV types and 10 low-risk HPV types |
Sensitivity: | 98% |
Sample type: | Cervical exfoliated cells, genitourinary secretions |
Specificity: | 98% |
Reproducibility: | 98% |
Analysis mode: | PCR-reverse dot hybridization |
Application: | It is suitable for the genetic diagnosis of clinical HPV infection, assists in the screening of condyloma acuminatum and cervical cancer, and monitors the therapeutic effect. It can provide scientific basis for the diagnosis of patients with HPV related diseases. |
Cervical cancer is the only cancer that has a clear cause, can be detected, prevented, and eliminated early. The International Cancer Society believes that persistent high-risk HPV virus infection is the main cause of cervical cancer. HPV typing can be used to determine the risk of cervical cancer and achieve individualized tumor prevention and treatment. Different types of HPV infection have different risks of cervical cancer. Typing testing can provide guidance for risk assessment and epidemiological investigation. It can also guide the shunt processing of cervical cytology test results ASCUS and LSIL, rule out suspicious lesions and low-grade lesions, improve diagnosis reliability and reduce the risk of missed diagnosis.
Copyright © 2024 Creative Biogene. All rights reserved.